Vandetanib Plus Pemetrexed Vs Pemetrexed as 2nd-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (Nsclc); a Randomized, Double- Blind Phase Iii Trial
Resource
EJC SUPPLEMENTS v.7 n.2 pp.506-506
Journal
EJC SUPPLEMENTS
Journal Volume
v.7
Journal Issue
n.2
Pages
506-506
Date Issued
2009
Date
2009
Author(s)
YANG, CHIH-HSIN
SDGs